Roy R. Teller

Array ( [id] => 4853104 [patent_doc_number] => 20080318847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction' [patent_app_type] => utility [patent_app_number] => 11/914049 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5489 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318847.pdf [firstpage_image] =>[orig_patent_app_number] => 11914049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436167 [patent_doc_number] => 20090170754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'TREATING LIVER DISEASES' [patent_app_type] => utility [patent_app_number] => 11/915107 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9326 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170754.pdf [firstpage_image] =>[orig_patent_app_number] => 11915107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271117 [patent_doc_number] => 20090074893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Antiviral peptides' [patent_app_type] => utility [patent_app_number] => 11/919518 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3974 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074893.pdf [firstpage_image] =>[orig_patent_app_number] => 11919518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661531 [patent_doc_number] => 20060252127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Factor VII or VIIa - Like Molecules' [patent_app_type] => utility [patent_app_number] => 11/379189 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29147 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252127.pdf [firstpage_image] =>[orig_patent_app_number] => 11379189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602889 [patent_doc_number] => 20060293234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Therapeutic peptides for the treatment of metastatic cancer' [patent_app_type] => utility [patent_app_number] => 11/404959 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8087 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293234.pdf [firstpage_image] =>[orig_patent_app_number] => 11404959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 587904 [patent_doc_number] => 07439227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Use of selected cyclosporins for the treatment of hepatitis C infection' [patent_app_type] => utility [patent_app_number] => 11/406800 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8885 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439227.pdf [firstpage_image] =>[orig_patent_app_number] => 11406800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247354 [patent_doc_number] => 20070243588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Factor VII or VIIa - Like Molecules' [patent_app_type] => utility [patent_app_number] => 11/279541 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29159 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243588.pdf [firstpage_image] =>[orig_patent_app_number] => 11279541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620010 [patent_doc_number] => 20060189544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Integrin-Mediated drug targeting' [patent_app_type] => utility [patent_app_number] => 11/399985 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49873 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189544.pdf [firstpage_image] =>[orig_patent_app_number] => 11399985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92209 [patent_doc_number] => 07732406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Use of natriuretic peptide for treating heart failure' [patent_app_type] => utility [patent_app_number] => 11/400696 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16109 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732406.pdf [firstpage_image] =>[orig_patent_app_number] => 11400696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239941 [patent_doc_number] => 20120148673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'PEPTIDES THAT DOWN REGULATE THE ACTIVITY OF PLASMA MEMBRANE TRANSPORTERS INCLUDING SODIUM-D-GLUCOSE COTRANSPORTER SGLT1' [patent_app_type] => utility [patent_app_number] => 11/910597 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26959 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552758 [patent_doc_number] => 20090286744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Treatment of asthma' [patent_app_type] => utility [patent_app_number] => 11/887105 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1191 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286744.pdf [firstpage_image] =>[orig_patent_app_number] => 11887105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850516 [patent_doc_number] => 20060233707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Process for producing an injectable medicament preparation' [patent_app_type] => utility [patent_app_number] => 11/388733 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6719 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233707.pdf [firstpage_image] =>[orig_patent_app_number] => 11388733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4495171 [patent_doc_number] => 07947479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Bardet-Biedl susceptibility gene and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/370242 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37519 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947479.pdf [firstpage_image] =>[orig_patent_app_number] => 11370242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753170 [patent_doc_number] => 20080161245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Protein-Binding Anthracycline Peptide Derivatives and Drugs Containing Them' [patent_app_type] => utility [patent_app_number] => 11/885165 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5092 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161245.pdf [firstpage_image] =>[orig_patent_app_number] => 11885165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678313 [patent_doc_number] => 20060183669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Separation of polypeptides comprising a racemized amino acid' [patent_app_type] => utility [patent_app_number] => 11/358676 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11599 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183669.pdf [firstpage_image] =>[orig_patent_app_number] => 11358676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677356 [patent_doc_number] => 20060182711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Conjugates of an EPO moiety and a polymer' [patent_app_type] => utility [patent_app_number] => 11/357936 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24082 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182711.pdf [firstpage_image] =>[orig_patent_app_number] => 11357936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305878 [patent_doc_number] => 08227414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Highly potent full and partial agonists and antagonists of the nociceptin/orphanin FQ receptor' [patent_app_type] => utility [patent_app_number] => 11/884241 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8764 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11884241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955379 [patent_doc_number] => 20080188403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Parenteral Combination Therapy For Infective Conditions With Drug Resistant Bacterium' [patent_app_type] => utility [patent_app_number] => 11/816179 [patent_app_country] => US [patent_app_date] => 2006-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6819 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188403.pdf [firstpage_image] =>[orig_patent_app_number] => 11816179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314850 [patent_doc_number] => 07524820 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-04-28 [patent_title] => 'Compounds of therapeutic value in the treatment of multiple sclerosis and other diseases wherein foamy cells are involved in the disease etiology' [patent_app_type] => utility [patent_app_number] => 11/346761 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524820.pdf [firstpage_image] =>[orig_patent_app_number] => 11346761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277989 [patent_doc_number] => 20090130121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Synthetic Peptide Copolymers for Treatment and Prevention of Cardiovascular Disorders' [patent_app_type] => utility [patent_app_number] => 11/883734 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10716 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130121.pdf [firstpage_image] =>[orig_patent_app_number] => 11883734 [rel_patent_id] =>[rel_patent_doc_number] =>)